A Study of the Efficacy, Safety and Tolerability of Chronocort in Treating CAH
Status:
Active, not recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
Subjects completing study DIUR-005 and those who have already completed study DIUR-003 will
be offered the opportunity either to continue Chronocort® therapy or to switch from their
current glucocorticoid therapy to Chronocort® in this open-label study.